Insights on Safety and Clinical Guidance for Cannabinoid Use in Migraine: Nathaniel M. Schuster, MD

At AHS 2025, the associate clinic director at the UC San Diego talked about the cautious use of cannabinoids in migraine and the importance of standard therapies before cannabinoids. [WATCH TIME: 3 minutes]